https://doi.org/10.1038/s41467-022-33349-y
X
Xiaoqing Luo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
794
Citations
6
h-index
6
i10-index
Xiaoqing Luo is an academic researcher from Qingdao University. The author has contributed to research in topics: Cancer, Lipids, and Metabolism & Cancer, Hypoxia, and Metabolism & Peroxisome Proliferator-Activated Receptors. The author has an h-index of 6, co-authored 25 publications.
Papers by this author
worksCD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis
2022 · Nature Communications · 288 citations
The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis
2021 · Cell Death and Disease · 205 citations
https://doi.org/10.1038/s41419-021-03596-w
HIF-2α-induced upregulation of CD36 promotes the development of ccRCC
2022 · Experimental Cell Research · 22 citations
https://doi.org/10.1016/j.yexcr.2022.113389
The fatty acid receptor CD36 promotes macrophage infiltration via p110γ signaling to stimulate metastasis
2024 · Journal of Advanced Research · 13 citations
https://doi.org/10.1016/j.jare.2024.10.006
Successful treatment of severe pneumonia, pyopneumothorax with severe acute respiratory distress syndrome, and septic shock: a case report
2020 · European journal of medical research · 3 citations
https://doi.org/10.1186/s40001-020-00459-6
Prone versus lateral position in acute hypoxemic respiratory failure patients with HFNO therapy: study protocol for a multicentre randomised controlled open-label trial
2023 · Trials · 3 citations
https://doi.org/10.1186/s13063-023-07761-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat